Investors are closely watching Eli Lilly & Company (LLY) as the pharmaceutical giant prepares to release its fiscal third-quarter results later this week. Analysts are expecting strong results driven by the robust https://denisgmwr146730.onesmablog.com/analyzing-eli-lilly-s-q3-results-77808810